FRACTA THERAPEUTICS AS
Under liquidation: 08/28/2026, Voluntary liquidation
Å utvikle, produsere og selge produkter innenfor bioteknologi og
tilgrensende områder. Formålet kan fremmes ved deltagelse i eller
samarbeid med andre foretak i inn- og utland eller rådgivende
virksomhet.
Utvikling, produksjon og salg av bioteknologiske produkter.
Organization
- Chairman of the board
- SØ
- Years since formation
- 5 years
- since Apr 19, 2021
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 12,000
- 1 share class
- Total number of shareholders
- 3
- companies
Financials
- Annual total result 2025
- -116,177
- NOK
- Total equity 2025
- -27,413
- NOK
Last update: Aug 28, 2026
Management
Board
| Name | Role | Shares |
|---|---|---|
SØ | Chairman | 33.33 % indirectly |
EM 1989 | Board Member | 33.33 % indirectly |
TE | Board Member | 33.33 % indirectly |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
EM 1989 | Board Member | 33.33 % indirectly |
TE | Board Member | 33.33 % indirectly |
SØ | Chairman | 33.33 % indirectly |
Last update: Oct 29, 2024
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 4,000 | 33.33 % | |
| Ordinary shares | 4,000 | 33.33 % | |
| Ordinary shares | 4,000 | 33.33 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 0 | 225,000 | 0 | 0 | 0 |
Annual Total Result | -116,177 | 4,498 | -25,225 | -16,890 | -6,049 |
Total assets | 9,242 | 15,775 | 4,266 | 1,491 | 18,382 |
Total liabilities | 36,655 | 2,011 | 28,000 | 0 | 0 |
Total equity | -27,413 | 13,764 | -23,734 | 1,491 | 18,382 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 0 | 225,000 | 0 | 0 | 0 |
Total operating costs | 115,845 | 220,213 | 25,225 | 16,890 | 6,049 |
Operating result | -115,845 | 4,787 | -25,225 | -16,890 | -6,049 |
Financial income/costs | -332 | -289 | 0 | 0 | 0 |
Profit before tax | -116,177 | 4,498 | -25,225 | -16,890 | -6,049 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 | 0 |
Annual Total Result | -116,177 | 4,498 | -25,225 | -16,890 | -6,049 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 0 | 0 | 0 | 0 | 0 |
Total current assets | 9,242 | 15,775 | 4,266 | 1,491 | 18,382 |
Total assets | 9,242 | 15,775 | 4,266 | 1,491 | 18,382 |
Short term debt | 3,655 | 2,011 | 0 | 0 | 0 |
Long term debt | 33,000 | 0 | 28,000 | 0 | 0 |
Total liabilities | 36,655 | 2,011 | 28,000 | 0 | 0 |
Contributed capital | 132,430 | 57,430 | 24,430 | 24,430 | 24,430 |
Retained earnings | -159,843 | -43,666 | -48,164 | -22,939 | -6,049 |
Total equity | -27,413 | 13,764 | -23,734 | 1,491 | 18,382 |
Total equity and liabilities | 9,242 | 15,775 | 4,266 | 1,491 | 18,382 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises